96447-49-3

Usage

InChI:InChI=1/C12H15N5OS/c1-8-10(14-12(19)15-13)11(18)17(16(8)2)9-6-4-3-5-7-9/h3-7H,13H2,1-2H3,(H2,14,15,19)

Upstream product

• 21487-33-2 1-allyl-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-thiourea 
• 93126-71-7 (1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-dithiocarbamic acid methyl ester 
• 83-07-8 4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one 

Downstream Products

• 249516-41-4 C₂₁H₂₀N₆O₃S 
• 249516-38-9 C₂₀H₁₈N₆O₂S 
• 249516-33-4 C₁₉H₁₈ClN₅OS 
• 249516-35-6 C₁₉H₁₈N₆O₃S 
• 99020-96-9 1-benzylidene-4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-thiosemicarbazide 
• 249516-28-7 C₂₀H₂₁N₅O₂S 
• 249516-30-1 4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-(2-hydroxy-benzylidene)-thiosemicarbazide 
• 249516-32-3 C₂₀H₂₁N₅O₃S 
• 249516-29-8 C₂₁H₂₃N₅O₃S 
• 249516-34-5 C₁₉H₁₈BrN₅OS 
• 249516-31-2 C₁₉H₁₈N₆O₄S 

Relevant academic research and scientific papers

Synthesis, spectroscopic characterization, DFT and antibacterial studies of newly synthesized cobalt(II, III), nickel(II) and copper(II) complexes with salicylaldehyde N(4)-antipyrinylthiosemicarbazone

Salicylaldehyde N(4)-antipyrinylthiosemicarbazone (H2L) and its complexes of Co(III, II), Ni(II) and Cu(II) have been prepared and characterized. Elemental analyses, molar conductivities, magnetic measurements, spectral (IR, UV–vis, 1H and 13C NMR and ESR) and thermogravimetric studies have been used to characterize the complexes. The infrared spectra show that the thiosemicarbazone ligand behaves as tridentate ligand (ONS), either in the thione or thiolato form. Stereochemistries are proposed for the complexes on the basis of both spectral and magnetic properties. Along with the experimental spectral data of the starting ligand, its corresponding predicted ones were obtained using the state of art density functional theory (DFT) in gas and solvent phases. The obtained results showed a relatively good correlation between the calculated and experimental spectral data. Some of the complexes showed antibacterial activity against Staphylococcus aureus and Escherichia coli representing Gram-positive and Gram-negative bacteria respectively when compared with Enrofloxacin as a standard antibiotic.

Synthesis, spectroscopic, electrochemical characterization, density functional theory (DFT), time dependent density functional theory (TD-DFT), and antibacterial studies of some Co(II), Ni(II), and Cu(II) chelates of (E)-4-(1,5-dimethyl-3-oxo-2-phenyl-2,3

In this study, mononuclear Co(II), Ni(II), and Cu(II) chelates of the potentially tridentate O, N, S donor ligand (E)-4-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-(3-hydroxynaphthalen-2-yl)methylene) thiosemicarbazide (H2L) wer

Synthesis, characterization, and in vivo anti-cancer activity of new metal complexes derived from isatin-N(4)antipyrinethiosemicarbazone ligand against ehrlich ascites carcinoma cells

The current study aimed to synthesize new metal coordination complexes with potential biomedical applications. Metal complexes were prepared via the reaction of isatin-N(4)antipyrinethiosemicarbazone ligand 1 with Cu(II), Ni(II), Co(II), Zn(II), and Fe(III) ions. The obtained metal complexes 2-12 were characterized using elemental, spectral (1H-NMR, EPR, Mass, IR, UV-Vis) and thermal (TGA) techniques, as well as magnetic moment and molar conductance measurements. In addition, their geometries were studied using EPR and UV-Vis spectroscopy. To evaluate the in vivo anti-cancer activities of these complexes, the ligand 1 and its metal complexes 2, 7 and 9 were tested against solid tumors. The solid tumors were induced by subcutaneous (SC) injection of Ehrlich ascites carcinoma (EAC) cells in mice. The impact of the selected complexes on the reduction of tumor volume was determined. Also, the expression levels of vascular endothelial growth factor (VEGF) and cysteine aspartyl-specific protease-7 (caspase-7) in tumor and liver tissues of mice bearing EAC tumor were determined. Moreover, their effects on alanine transaminase (ALT), aspartate transaminase (AST), albumin, and glucose levels were measured. The results revealed that the tested compounds, especially complex 9, reduced tumor volume, inhibited the expression of VEGF, and induced the expression of caspase-7. Additionally, they restored the levels of ALT, AST, albumin, and glucose close to their normal levels. Taken together, our newly synthesized metal complexes are promising anti-cancer agents against solid tumors induced by EAC cells as supported by the inhibition of VEGF and induction of caspase-7.

New thiazolidones-4 with pyrazolone-5 substituent as the potential NSAIDs

The synthesis of a group of thiazolidine derivatives with pyrazolone-5 substituent is described. The structure of the new compounds is supported by 1H- and 13C-NMR spectra. Group of compounds was tested in vivo for their antiinflammatory activity. The obtained results gave the opportunity to separate the perspective groups of potential NSAIDs, which have got greater antiinflammatory activity than the best standard drugs.